Hepatitis B immunoglobulin (Sinopharm Shanghai Plasma)

乙型肝炎人免疫球蛋白（国药上海血液）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHepatitis B immunoglobulin (Sinopharm Shanghai Plasma)
Drug Alias NameN/A
ClassificationBiologics > Blood componentsBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsHepatitis B
Approved Indications in ChinaHepatitis B
Original Approved Country/TerritoryMainland China
Original Approved Date1999/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSinopharm Shanghai Plasma-Derived Biotherapies Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSinopharm Shanghai Plasma-Derived Biotherapies Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeJ06BB04
Related LinksN/A